Teva Pharmaceuticals USA, Inc: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Lab
Read the official notice at FDA (drug) →
Get alerts for Teva Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Teva Pharmaceuticals USA, Inc
- Product
- Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
- Reason / hazard
- CGMP Deviations: use of an unapproved raw material
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Within U.S
- Recall initiated
- 2026-03-19
- Code info
- Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.
- Product quantity
- 113,943 Cartons
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Parsippany
- State
- NJ
- Country
- United States
- Event id
- 98614
Free daily digest + "My products" watchlist